NO20042208L - Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter - Google Patents

Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter

Info

Publication number: NO20042208L
Authority: NO; Norway
Prior art keywords: treatment; pelvic pain; administered anti; vaginally administered; dysrhythmic
Prior art date: 2001-10-29

Application number

NO20042208A

Other languages

English (en)

Other versions

NO333544B1 (no

Inventor

Howard L Levine

William J Bologna

Dominique De Ziegler

Original Assignee

Columbia Lab Bermuda Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-29

Filing date

2004-05-28

Publication date

2004-07-29

2004-05-28 Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd

2004-07-29 Publication of NO20042208L publication Critical patent/NO20042208L/no

2013-07-08 Publication of NO333544B1 publication Critical patent/NO333544B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Pregnancy & Childbirth (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20042208A 2001-10-29 2004-05-28 Farmasoytisk vaginalsammensetning til reduksjon eller lindring av uterin dysrytmi samt anvendelse derav NO333544B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33068401P	2001-10-29	2001-10-29
US10/278,912 US20030114394A1 (en)	2001-10-29	2002-10-24	Vaginally administered anti-dysrhythmic agents for treating pelvic pain
PCT/EP2002/012042 WO2003037381A1 (en)	2001-10-29	2002-10-28	Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility

Publications (2)

Publication Number	Publication Date
NO20042208L true NO20042208L (no)	2004-07-29
NO333544B1 NO333544B1 (no)	2013-07-08

Family

ID=26959337

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042208A NO333544B1 (no)	2001-10-29	2004-05-28	Farmasoytisk vaginalsammensetning til reduksjon eller lindring av uterin dysrytmi samt anvendelse derav

Country Status (33)

Country	Link
US (1)	US20030114394A1 (no)
EP (2)	EP1764111B1 (no)
JP (2)	JP2005511564A (no)
KR (2)	KR20050040820A (no)
CN (1)	CN100404072C (no)
AR (1)	AR037048A1 (no)
AT (2)	ATE451123T1 (no)
AU (1)	AU2002350644B2 (no)
BR (1)	BR0213585A (no)
CA (1)	CA2465132C (no)
CY (2)	CY1106000T1 (no)
DE (2)	DE60234725D1 (no)
DK (2)	DK1764111T3 (no)
ES (2)	ES2275928T3 (no)
GE (1)	GEP20094614B (no)
HR (1)	HRP20040479B1 (no)
HU (1)	HUP0402389A3 (no)
IL (3)	IL161513A0 (no)
MA (1)	MA26230A1 (no)
ME (1)	ME00255B (no)
MX (1)	MXPA04003976A (no)
MY (2)	MY145215A (no)
NO (1)	NO333544B1 (no)
NZ (1)	NZ532295A (no)
PE (1)	PE20030692A1 (no)
PL (2)	PL402549A1 (no)
PT (2)	PT1441770E (no)
RS (1)	RS51414B (no)
RU (2)	RU2476212C2 (no)
SI (2)	SI1764111T1 (no)
UA (1)	UA90077C2 (no)
WO (1)	WO2003037381A1 (no)
ZA (1)	ZA200402944B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7344732B2 (en) *	2002-01-10	2008-03-18	Kimberly-Clark Worldwide, Inc.	Medicated tampon
US7341737B2 (en) *	1997-06-11	2008-03-11	Kimberly-Clark Worldwide, Inc.	Medicated tampon
CH697081A5 (de) *	2002-01-22	2008-04-30	Andreas F Dr Schaub	Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US20050244402A1 (en) *	2004-04-30	2005-11-03	Villanueva Julie M	Absorption of pain-causing agents
DE102004054552A1 (de) *	2004-11-11	2006-05-18	Hcb Happy Child Birth Holding Ag	Neue Zusammensetzung zur Erleichterung der Humangeburt
US7919453B2 (en)	2005-03-25	2011-04-05	Kimberly-Clark Worldwide, Inc.	Dosage cap assembly for an applicator
US7993667B2 (en)	2005-03-25	2011-08-09	Kimberly-Clark Worldwide, Inc.	Methods of manufacturing a medicated tampon assembly
US7744556B2 (en)	2005-03-25	2010-06-29	Kimberly-Clark Worldwide, Inc.	Delivery tube assembly for an applicator
US7527614B2 (en)	2005-03-25	2009-05-05	Kimberly-Clark Worldwide, Inc.	Protective tube for a medicated tampon
US7708726B2 (en)	2005-04-28	2010-05-04	Kimberly-Clark Worldwide, Inc.	Dosage form cap for an applicator
US20070253994A1 (en) *	2006-04-28	2007-11-01	Medtronic, Inc.	Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
WO2008039995A2 (en) *	2006-09-28	2008-04-03	Vance Products Incorporated, D/Ba Cook Urological Incorporated	Medical device including a bioactive in a non-ionic and an ionic form and methods of preparation thereof
WO2008042227A1 (en) *	2006-09-28	2008-04-10	Med Institute, Inc.	Medical device including an anesthetic and method of preparation thereof
WO2008042228A2 (en) *	2006-09-28	2008-04-10	Med Institute, Inc.	Medical devices incorporating a bioactive and methods of preparing such devices
EP3470055A1 (en) *	2007-06-26	2019-04-17	Allergan Pharmaceuticals International Limited	Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
US8956642B2 (en) *	2008-04-18	2015-02-17	Medtronic, Inc.	Bupivacaine formulation in a polyorthoester carrier
US8475823B2 (en) *	2008-04-18	2013-07-02	Medtronic, Inc.	Baclofen formulation in a polyorthoester carrier
DK2282779T3 (da)	2008-04-29	2013-05-27	Pharnext	Nye terapeutiske fremgangsmåder til behandling af alzheimer sygdom og beslægtede lidelser gennem en modulation af cellestress-respons
BRPI0803568B8 (pt) *	2008-08-14	2021-05-25	Biolab San Us Farm Ltda	composição mucoaderente
RU2538674C2 (ru) *	2012-09-10	2015-01-10	Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ")	Фармацевтическая композиция, обладающая пролонгированной противоаритмической активностью
US9700549B2 (en)	2013-10-03	2017-07-11	David Wise	Compositions and methods for treating pelvic pain and other conditions
JP6654057B2 (ja) *	2016-02-10	2020-02-26	国立大学法人筑波大学	局所麻酔薬を含有するポリイオンコンプレックスを有効成分とする局所疼痛制御用組成物
WO2017165707A1 (en) *	2016-03-24	2017-09-28	Juniper Pharmaceuticals, Inc.	Vaginal administration of agents for treating and preventing pain associated with gynecological medical procedures
BR102018008324A2 (pt) *	2018-04-25	2019-11-05	Laboratorios Ferring Ltda	composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3387419A (en) *	1965-10-22	1968-06-11	Kamberg Henry	Decking with trim strip
JPH0830004B2 (ja) *	1983-11-14	1996-03-27	コロンビアラボラトリーズインコーポレイテッド	生物接着性組成物およびそれにより治療する方法
US5446070A (en) *	1991-02-27	1995-08-29	Nover Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) *	1991-02-27	1993-08-10	Noven Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
US5387419A (en) *	1988-03-31	1995-02-07	The University Of Michigan	System for controlled release of antiarrhythmic agents
WO1991006290A1 (en) *	1989-11-03	1991-05-16	Riker Laboratories, Inc.	Bioadhesive composition and patch
US5332576A (en) *	1991-02-27	1994-07-26	Noven Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
IT1250421B (it) *	1991-05-30	1995-04-07	Recordati Chem Pharm	Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5700485A (en) *	1992-09-10	1997-12-23	Children's Medical Center Corporation	Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5508045A (en) *	1992-10-09	1996-04-16	The Regents Of The University Of California	Method and agents for control and management of labor during pregnancy
US5543150A (en) *	1993-09-15	1996-08-06	Columbia Laboratories, Inc.	Method of progesterone delivery and affect thereof
US5667492A (en) *	1994-10-07	1997-09-16	Columbia Laboratories, Inc.	Use and composition of an anti-sexually transmitted diseases formulation
GB9610359D0 (en) *	1996-05-17	1996-07-24	Edko Trading Representation	Pharmaceutical compositions
US5663492A (en) *	1996-06-05	1997-09-02	Alapati; Rama Rao	System for continuous analysis and modification of characteristics of a liquid hydrocarbon stream
US5985861A (en) *	1996-11-04	1999-11-16	Columbia Laboratories, Inc.	Progesterone for treating or reducing ischemia
US5993856A (en) *	1997-01-24	1999-11-30	Femmepharma	Pharmaceutical preparations and methods for their administration
US5977143A (en) *	1997-02-15	1999-11-02	Edelstam; Greta	Medicament against infertility which reduces phagocytosis of spermatozoa in women
US6210710B1 (en) *	1997-04-28	2001-04-03	Hercules Incorporated	Sustained release polymer blend for pharmaceutical applications
CA2207227A1 (en) *	1997-06-09	1998-12-09	Johnson & Johnson Inc.	Plant seed germination mat
US6197327B1 (en) *	1997-06-11	2001-03-06	Umd, Inc.	Device and method for treatment of dysmenorrhea
US5989535A (en) *	1997-08-15	1999-11-23	Soma Technologies	Polymeric bioadhesive emulsions and suspensions and methods of treatment
DE69819748T2 (de) *	1997-09-12	2004-09-30	Columbia Laboratories (Bermuda) Ltd.	Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6248358B1 (en) *	1998-08-25	2001-06-19	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets and methods of making and using the same
EP1021204B1 (en) *	1997-09-26	2005-12-28	Noven Pharmaceuticals, Inc.	Bioadhesive compositions and methods for topical administration of active agents
US6135153A (en) *	1998-01-02	2000-10-24	Cleland, Sr. John	Anesthesia delivery systems and methods
AU752285B2 (en) *	1998-05-07	2002-09-12	University Of Maryland At Baltimore	A method for diagnosing and treating chronic pelvic pain syndrome
US6207696B1 (en) *	1998-09-15	2001-03-27	Cytos Pharamaceuticals, Llc	Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
US6486207B2 (en) *	1998-12-10	2002-11-26	Nexmed (Holdings), Inc.	Compositions and methods for amelioration of human female sexual dysfunction
US6264973B1 (en) *	1999-08-26	2001-07-24	Fei Enterprises, Ltd.	Apparatus and method for anesthetizing the cervical region of a female
EP1212051A4 (en) *	1999-08-27	2004-03-31	Merck & Co Inc	METHOD FOR TREATING OR PREVENTING CHEMICAL PROSTATITIS OR CHRONIC POOL PAIN
US20020013331A1 (en) *	2000-06-26	2002-01-31	Williams Robert O.	Methods and compositions for treating pain of the mucous membrane

2002
- 2002-10-24 US US10/278,912 patent/US20030114394A1/en not_active Abandoned
- 2002-10-28 RU RU2008133235/15A patent/RU2476212C2/ru not_active IP Right Cessation
- 2002-10-28 BR BR0213585-0A patent/BR0213585A/pt active Search and Examination
- 2002-10-28 DE DE60234725T patent/DE60234725D1/de not_active Expired - Lifetime
- 2002-10-28 KR KR1020047006271A patent/KR20050040820A/ko not_active Ceased
- 2002-10-28 ES ES02785326T patent/ES2275928T3/es not_active Expired - Lifetime
- 2002-10-28 SI SI200230886T patent/SI1764111T1/sl unknown
- 2002-10-28 EP EP06024500A patent/EP1764111B1/en not_active Expired - Lifetime
- 2002-10-28 PE PE2002001058A patent/PE20030692A1/es not_active Application Discontinuation
- 2002-10-28 CN CNB028215656A patent/CN100404072C/zh not_active Expired - Fee Related
- 2002-10-28 UA UA20040403211A patent/UA90077C2/uk unknown
- 2002-10-28 MY MYPI2010004778A patent/MY145215A/en unknown
- 2002-10-28 PL PL402549A patent/PL402549A1/pl not_active Application Discontinuation
- 2002-10-28 PT PT02785326T patent/PT1441770E/pt unknown
- 2002-10-28 ES ES06024500T patent/ES2336238T3/es not_active Expired - Lifetime
- 2002-10-28 IL IL16151302A patent/IL161513A0/xx unknown
- 2002-10-28 ME MEP-2008-349A patent/ME00255B/me unknown
- 2002-10-28 AU AU2002350644A patent/AU2002350644B2/en not_active Ceased
- 2002-10-28 PL PL02369790A patent/PL369790A1/xx not_active IP Right Cessation
- 2002-10-28 MX MXPA04003976A patent/MXPA04003976A/es active IP Right Grant
- 2002-10-28 EP EP02785326A patent/EP1441770B1/en not_active Expired - Lifetime
- 2002-10-28 RS YUP-367/04A patent/RS51414B/sr unknown
- 2002-10-28 DK DK06024500.8T patent/DK1764111T3/da active
- 2002-10-28 GE GEAP20028235A patent/GEP20094614B/en unknown
- 2002-10-28 AT AT06024500T patent/ATE451123T1/de active
- 2002-10-28 DK DK02785326T patent/DK1441770T3/da active
- 2002-10-28 AR ARP020104079A patent/AR037048A1/es unknown
- 2002-10-28 CA CA2465132A patent/CA2465132C/en not_active Expired - Fee Related
- 2002-10-28 HR HR20040479A patent/HRP20040479B1/xx not_active IP Right Cessation
- 2002-10-28 PT PT06024500T patent/PT1764111E/pt unknown
- 2002-10-28 WO PCT/EP2002/012042 patent/WO2003037381A1/en not_active Ceased
- 2002-10-28 SI SI200230452T patent/SI1441770T1/sl unknown
- 2002-10-28 RU RU2004116346/15A patent/RU2345758C2/ru not_active IP Right Cessation
- 2002-10-28 MY MYPI20024018A patent/MY149482A/en unknown
- 2002-10-28 DE DE60216495T patent/DE60216495T2/de not_active Expired - Lifetime
- 2002-10-28 HU HU0402389A patent/HUP0402389A3/hu unknown
- 2002-10-28 KR KR1020107016839A patent/KR20100088718A/ko not_active Ceased
- 2002-10-28 AT AT02785326T patent/ATE346614T1/de active
- 2002-10-28 NZ NZ532295A patent/NZ532295A/en not_active IP Right Cessation
- 2002-10-28 JP JP2003539721A patent/JP2005511564A/ja active Pending
2004
- 2004-04-19 IL IL161513A patent/IL161513A/en not_active IP Right Cessation
- 2004-04-19 ZA ZA2004/02944A patent/ZA200402944B/en unknown
- 2004-04-29 MA MA27663A patent/MA26230A1/fr unknown
- 2004-05-28 NO NO20042208A patent/NO333544B1/no not_active IP Right Cessation
2007
- 2007-02-09 CY CY20071100173T patent/CY1106000T1/el unknown
2010
- 2010-02-25 CY CY20101100180T patent/CY1110288T1/el unknown
2011
- 2011-02-17 IL IL211288A patent/IL211288A/en not_active IP Right Cessation
- 2011-05-31 JP JP2011121273A patent/JP2011201909A/ja active Pending

Also Published As

Publication number	Publication date
AR037048A1 (es)	2004-10-20
DE60216495D1 (de)	2007-01-11
JP2005511564A (ja)	2005-04-28
RU2004116346A (ru)	2005-03-10
HRP20040479B1 (en)	2009-02-28
ME00255B (me)	2011-05-10
BR0213585A (pt)	2004-08-24
MY145215A (en)	2012-01-13
PT1764111E (pt)	2010-01-29
RS36704A (sr)	2006-10-27
PT1441770E (pt)	2007-01-31
RU2008133235A (ru)	2010-02-20
KR20050040820A (ko)	2005-05-03
CA2465132A1 (en)	2003-05-08
CY1106000T1 (el)	2011-04-06
MY149482A (en)	2013-08-30
US20030114394A1 (en)	2003-06-19
PE20030692A1 (es)	2003-08-28
AU2002350644B2 (en)	2008-05-08
SI1764111T1 (sl)	2010-04-30
UA90077C2 (uk)	2010-04-12
RU2476212C2 (ru)	2013-02-27
MA26230A1 (fr)	2004-07-01
IL161513A0 (en)	2004-09-27
KR20100088718A (ko)	2010-08-10
EP1764111B1 (en)	2009-12-09
ATE346614T1 (de)	2006-12-15
NZ532295A (en)	2006-12-22
HK1102221A1 (en)	2007-11-09
RS51414B (sr)	2011-02-28
MEP34908A (bs)	2011-02-10
DK1764111T3 (da)	2010-04-06
CA2465132C (en)	2012-04-24
CY1110288T1 (el)	2015-01-14
EP1764111A1 (en)	2007-03-21
HRP20040479A2 (en)	2004-10-31
HUP0402389A2 (hu)	2005-03-29
IL211288A (en)	2014-02-27
CN100404072C (zh)	2008-07-23
DE60216495T2 (de)	2007-07-26
HK1063293A1 (en)	2004-12-24
HUP0402389A3 (en)	2012-09-28
MXPA04003976A (es)	2004-07-08
ES2275928T3 (es)	2007-06-16
EP1441770B1 (en)	2006-11-29
IL211288A0 (en)	2011-04-28
JP2011201909A (ja)	2011-10-13
EP1441770A1 (en)	2004-08-04
ATE451123T1 (de)	2009-12-15
GEP20094614B (en)	2009-02-25
PL402549A1 (pl)	2013-08-05
CN1578675A (zh)	2005-02-09
DK1441770T3 (da)	2007-03-19
IL161513A (en)	2011-12-29
ZA200402944B (en)	2005-03-30
SI1441770T1 (sl)	2007-02-28
DE60234725D1 (de)	2010-01-21
WO2003037381A1 (en)	2003-05-08
RU2345758C2 (ru)	2009-02-10
PL369790A1 (en)	2005-05-02
NO333544B1 (no)	2013-07-08
ES2336238T3 (es)	2010-04-09

Publication	Publication Date	Title
NO20042208L (no)	2004-07-29	Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
IL196301A0 (en)	2009-09-22	Medicament for the treatment of hapatitis c
IL159344A0 (en)	2004-06-01	Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL163725A0 (en)	2005-12-18	Administration of agents for the treatment of inflammation
EP1416884A4 (en)	2007-03-07	DISTRIBUTION OF AGENTS WITH THERAPEUTIC PROPERTIES
PL362711A1 (en)	2004-11-02	Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL157320A0 (en)	2004-02-19	Rapid-onset medicament for the treatment of sexual dysfunction
CY2009002I2 (el)	2009-11-04	Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
FIU20060389U0 (fi)	2006-09-22	Luusairauksien hoito
IL151890A0 (en)	2003-04-10	Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL157593A0 (en)	2004-03-28	Carbamate compounds for use in the treatment of pain
IL151891A0 (en)	2003-04-10	Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en)	2003-04-10	Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20026219L (no)	2003-02-17	Forbindelser for behandling av svekket fundisk relaksasjon
EP1411985A4 (en)	2006-06-07	TREATMENT OF PARASITICAL DISEASES
IL155237A0 (en)	2003-11-23	Combination therapy for the treatment of estrogen-sensitive disease
NO20013651D0 (no)	2001-07-25	Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
EE200300434A (et)	2003-12-15	Farmatseutiliselt toimivate ühendite kasutamine
ITMI20011820A0 (it)	2001-08-28	Trattamento di ustioni
NO20042166L (no)	2004-05-25	Kombinasjonsterapi for behandling av sykdom
EP1451308A4 (en)	2004-11-17	THERAPEUTIC USE OF AZIRIDINO COMPOUNDS
GB0222282D0 (en)	2002-10-30	Therapeutic device for the treatment of symptons caused by diseases
GB0219811D0 (en)	2002-10-02	Treatment of excreta
NO20015947D0 (no)	2001-12-05	Anordning for terapeutisk behandling av kroppsvev
GB0118564D0 (en)	2001-09-19	Therapeutic treatment for tinnitus

Legal Events

Date	Code	Title	Description
2017-05-29	MM1K	Lapsed by not paying the annual fees